Vineet Laboratories (NSE:VINEETLAB) ROCE %: 33.64% (As of Dec. 2025)


NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
38 GF Score
Price ₹34.00
GF Value ₹15.42
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories ROCE %?

Vineet Laboratories NSE:VINEETLAB +0.18% 38 ROCE % is 33.64% as of Dec. 2025. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 38/100 and a GF Value™ of ₹15.42 (Significantly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vineet Laboratories's annualized ROCE % for the quarter that ended in Dec. 2025 was 33.64%.

Vineet Laboratories  (NSE:VINEETLAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vineet Laboratories ROCE % Related Terms

Vineet Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories ROCE % Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
Get a 7-Day Free Trial Premium Member Only 35.45 29.83 11.74 10.25 -55.53

Vineet Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.26 -158.80 -5.71 47.43 33.64
NSE:VINEETLAB
38GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vineet Laboratories ROCE % Calculation

Vineet Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=-169.448/( ( (1168.719 - 759.963) + (945.401 - 743.889) )/ 2 )
=-169.448/( (408.756+201.512)/ 2 )
=-169.448/305.134
=-55.53 %

Vineet Laboratories's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=76.504/( ( (906.449 - 679.04) + (0 - 0) )/ 1 )
=76.504/( ( 227.409 + 0 )/ 1 )
=76.504/227.409
=33.64 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 33.64% mean?
Vineet Laboratories (NSE:VINEETLAB) has a ROCE % of 33.64% as of Dec. 2025.
Is Vineet Laboratories' ROCE % too high?
Vineet Laboratories' current ROCE % is 33.64%. The Chemicals industry median ROCE % is 6.42. Vineet Laboratories' value of 33.64% is 424% above this industry median. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' ROCE % compare to DOW?
Vineet Laboratories' ROCE % of 33.64% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. Vineet Laboratories' value of 33.64% is 424% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.42, based on 1,595 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current ROCE % of 33.64% is 424% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current ROCE % is 33.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.42, compared to a current price of ₹34.00 — trading 120.5% above its estimated fair value. The current ROCE % is 33.64% and 424% above the Chemicals industry median of 6.42. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current ROCE % is 33.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹34.00 is trading 120.5% above its estimated GF Value™ of ₹15.42. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • ROCE %: 33.64%
  • GF Value™: ₹15.42 vs. price of ₹34.00 (120.5% above fair value)
  • GF Score™: 38/100 with 6 warning signs
  • Industry Position: 424% above the Chemicals median

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score

Get the complete analysis for NSE:VINEETLAB

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹34.00
Price
₹15.42
GF Value